{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:14:49Z","timestamp":1789906489380,"version":"4.0.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-infectious uveitis is a well-reported cause of blindness in more developed countries, however data from sub-Saharan Africa is lacking. Here we aim to describe the diseases associated with paediatric non-infectious uveitis and the effect of currently available treatment in this setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective observational analysis of children with non-infectious uveitis from January 2010 to December 2017, attending the tertiary paediatric rheumatology and ophthalmology referral units in Cape Town was conducted. Statistical analysis utilising STATA13 software was performed with\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05 considered significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-nine children were identified: median age at first visit of 74\u2009months (IQR 49\u201386\u2009months), female to male ratio of 0.9:1, predominantly of mixed ancestry (72.4%). Juvenile idiopathic arthritis associated uveitis (JIAU) (48.3%), idiopathic uveitis (41.4%), sarcoidosis (6.9%) and Behcet\u2019s disease (3.5%) were diagnosed. Chronic anterior uveitis (72.4%) was the most frequent finding. Fifty-five percent had complications at presentation and all children with idiopathic uveitis presented with cataracts.<\/jats:p>\n                    <jats:p>\n                      Only 6.5% of the JIA cohort had JIAU. All JIA children had chronic anterior uveitis. There were no differences between JIA children with uveitis and those without uveitis, for sex (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.68) and race (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.58). Significantly, children with uveitis presented at an overall younger age (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008), had oligo-articular JIA (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01) and were antinuclear antibody positive (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                    <jats:p>Children with idiopathic uveitis were predominantly male (66.6%) with chronic anterior uveitis (41.7%).<\/jats:p>\n                    <jats:p>Nineteen children (65.5%) in the cohort had inactive disease on treatment at 12\u2009months from diagnosis, which included 10 on topical corticosteroid therapy. At the last clinical visit 17 (58.6%) on standard initial therapy, 8 (27.6%) on tumour necrosis factor inhibitors and 2 on additional DMARDs were in remission. Five of these children still required topical corticosteroids. Surgery was performed in 41.4%, primarily in the idiopathic group. Visual acuity improved or was maintained on treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Current practice seems to detect children with potentially sight-threatening disease but the high rate of complications and the low percentage of children with JIAU raises concerns of delayed healthcare intervention. Tumour necrosis factor inhibitors have improved outcomes in refractory cases in this cohort, however further studies are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12969-021-00537-x","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T11:03:14Z","timestamp":1617274994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Paediatric non-infectious uveitis in Cape Town, South Africa: a retrospective review of disease characteristics and outcomes on immunomodulating treatment"],"prefix":"10.1186","volume":"19","author":[{"given":"Waheba","family":"Slamang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Tinley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Brice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3874-1704","authenticated-orcid":false,"given":"Christiaan","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"537_CR1","doi-asserted-by":"publisher","unstructured":"Tsirouki T, Dastiridou A, Symeonidis C, Tounakaki O, Brazitikou I, Kalogeropoulos C, Androudi S A focus on the epidemiology of Uveitis. Ocul Immunol Inflamm 2018;26(1):2\u201316. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1080\/09273948.2016.1196713","DOI":"10.1080\/09273948.2016.1196713"},{"key":"537_CR2","doi-asserted-by":"publisher","unstructured":"Bourne RRA, Flaxman SR, Braithwaite T, Cicinelli MV, Das A, Jonas JB, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(9):e888\u201397. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S2214109X17302930. https:\/\/doi.org\/10.1016\/S2214-109X(17)30293-0.","DOI":"10.1016\/S2214-109X(17)30293-0"},{"key":"537_CR3","doi-asserted-by":"publisher","unstructured":"Miserocchi E, Fogliato G, Modorati G, Bandello F. Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol. 2013;23(5):705\u2013717. https:\/\/doi.org\/https:\/\/doi.org\/10.5301\/ejo.5000278, Available from: Review on the Worldwide Epidemiology of Uveitis.","DOI":"10.5301\/ejo.5000278"},{"key":"537_CR4","doi-asserted-by":"publisher","unstructured":"Richard AI. Monocular blindness in Bayelsa state of Nigeria. Pan Afr Med J. 2010;4:6. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.4314\/pamj.v4i1.53607","DOI":"10.4314\/pamj.v4i1.53607"},{"key":"537_CR5","doi-asserted-by":"publisher","unstructured":"Potter AR. Causes of blindness and visual handicap in the Central African Republic. Br J Ophthalmol 1991;75(6):326\u2013328. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1136\/bjo.75.6.326","DOI":"10.1136\/bjo.75.6.326"},{"key":"537_CR6","doi-asserted-by":"crossref","unstructured":"Sherwin JC, Dean WH, Metcalfe NH. Causes of blindness at Nkhoma eye hospital, Malawi. Eur J Ophthalmol 2008;18(6):1002\u20131006. Available from: http:\/\/dx.doi.org\/10.1177\/112067210801800624","DOI":"10.1177\/112067210801800624"},{"key":"537_CR7","doi-asserted-by":"publisher","unstructured":"Carreras FJ, Rodr\u00edguez-Hurtado F, David H. Ophthalmology in Luanda (Angola): a hospital based report. Br J Ophthalmol 1995;79(10):926\u2013933. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1136\/bjo.79.10.926","DOI":"10.1136\/bjo.79.10.926"},{"key":"537_CR8","unstructured":"Statistics South Africa; Profile of persons living with disability 2016 https:\/\/www.statssa.gov.za\/publications\/P03012016 Accessed October 2019."},{"key":"537_CR9","doi-asserted-by":"publisher","unstructured":"London NJS, Rathinam SR, Cunningham ET Jr. The epidemiology of uveitis in developing countries. Int Ophthalmol Clin 2010;50(2):1\u201317. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1097\/IIO.0b013e3181d2cc6b","DOI":"10.1097\/IIO.0b013e3181d2cc6b"},{"issue":"1","key":"537_CR10","first-page":"4","volume":"19","author":"PD Wade","year":"2015","unstructured":"Wade PD, Ramyil AV. Aetiology of Uveitis in the Gambia, West Africa. J Ophthalmol Eastern Central Southern Afr. 2015;19(1):4\u20138.","journal-title":"J Ophthalmol Eastern Central Southern Afr"},{"key":"537_CR11","doi-asserted-by":"publisher","unstructured":"Schaftenaar E, Meenken C, Baarsma GS, Khosa NS, Luijendijk A, McIntyre JA, et al. Uveitis is predominantly of infectious origin in a high HIV and TB prevalence setting in rural South Africa. Br J Ophthalmol 2016;100(10):1312\u20131316. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1136\/bjophthalmol-2016-308645","DOI":"10.1136\/bjophthalmol-2016-308645"},{"key":"537_CR12","doi-asserted-by":"publisher","unstructured":"Ronday MJ, Stilma JS, Barbe RF, McElroy WJ, Luyendijk L, Kolk AH, et al. Aetiology of uveitis in Sierra Leone, West Africa. Br J Ophthalmol 1996;80(11):956\u2013961. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1136\/bjo.80.11.956","DOI":"10.1136\/bjo.80.11.956"},{"key":"537_CR13","doi-asserted-by":"publisher","unstructured":"Tinley C, Van Zyl L, Gr\u00f6tte R. Poststreptococcal syndrome uveitis in South African children. Br J Ophthalmol 2012;96(1):87\u201389. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1136\/bjo.2010.199315","DOI":"10.1136\/bjo.2010.199315"},{"key":"537_CR14","doi-asserted-by":"publisher","unstructured":"Chinniah K, Mody GM, Bhimma R, Adhikari M. Arthritis in association with human immunodeficiency virus infection in black African children: causal or coincidental? Rheumatology 2005;44(7):915\u2013920. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1093\/rheumatology\/keh636","DOI":"10.1093\/rheumatology\/keh636"},{"key":"537_CR15","doi-asserted-by":"publisher","unstructured":"Zaborowski AG, Parbhoo D, Chinniah K. Uveitis in children with human immunodeficiency virus\u2013associated arthritis. J AAPOS. 2008;12(6):608-10. https:\/\/doi.org\/10.1016\/j.jaapos.2008.04.011","DOI":"10.1016\/j.jaapos.2008.04.011"},{"key":"537_CR16","doi-asserted-by":"publisher","unstructured":"Rautenbach W, Steffen J, Smit D, Lecuona K, Esterhuizen T. Patterns of Uveitis at two University-based referral Centres in Cape Town, South Africa. Ocul Immunol Inflamm 2019;27(6):868\u2013874. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1080\/09273948.2017.1391954","DOI":"10.1080\/09273948.2017.1391954"},{"key":"537_CR17","doi-asserted-by":"publisher","unstructured":"Chronopoulos A, Roquelaure D, Souteyrand G, Seebach JD, Schutz JS, Thumann G. Aqueous humor polymerase chain reaction in uveitis--utility and safety. BMC Ophthalmol. 2016;16(1):189. Available from: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1186\/s12886-016-0369-z","DOI":"10.1186\/s12886-016-0369-z"},{"key":"537_CR18","doi-asserted-by":"publisher","unstructured":"Damato EM, Angi M, Romano MR, Semeraro F, Costagliola C. Vitreous analysis in the management of uveitis. Mediators Inflamm. 2012;2012:863418. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1155\/2012\/863418","DOI":"10.1155\/2012\/863418"},{"issue":"13","key":"537_CR19","first-page":"510","volume":"65","author":"IE Haffejee","year":"1984","unstructured":"Haffejee IE, Raga J, Coovadia HM. Juvenile chronic arthritis in black and Indian South African children. S Afr Med J. 1984;65(13):510\u20134 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6710254.","journal-title":"S Afr Med J"},{"key":"537_CR20","doi-asserted-by":"publisher","unstructured":"Chipeta J, Njobvu P, Wa-Somwe S, Chintu C, McGill PE, Bucala R. Clinical patterns of juvenile idiopathic arthritis in Zambia. Pediatr Rheumatol Online J;11(1):33. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1186\/1546-0096-11-33","DOI":"10.1186\/1546-0096-11-33"},{"key":"537_CR21","doi-asserted-by":"publisher","unstructured":"Adelowo OO, Umar A. Juvenile idiopathic arthritis among Nigerians: a case study. Clin Rheumatol 2010;29(7):757\u2013761. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1007\/s10067-010-1401-y","DOI":"10.1007\/s10067-010-1401-y"},{"issue":"1","key":"537_CR22","first-page":"1","volume":"1","author":"BH Olaosebikan","year":"2017","unstructured":"Olaosebikan BH, Akintayo RO, Animashaun BA, Adelowo OO. Juvenile idiopathic Arthritis in a new rheumatology Clinic in Nigeria. JARS Open Access Pub. 2017;1(1):1.","journal-title":"JARS Open Access Pub"},{"key":"537_CR23","doi-asserted-by":"publisher","unstructured":"Khairallah M, Yahia SB, Ladjimi A, Messaoud R, Zaouali S, Attia S, Jenzeri S, Jelliti B Pattern of uveitis in a referral Centre in Tunisia, North Africa. Eye 2007;21(1):33\u201339. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1038\/sj.eye.6702111","DOI":"10.1038\/sj.eye.6702111"},{"key":"537_CR24","doi-asserted-by":"publisher","unstructured":"Allali F, Benomar A, Karim A, Lazrak N, Mohcine Z, El Yahyaoui M, et al. Beh\u00e7et\u2019s disease in Moroccan children: a report of 12 cases. Scand J Rheumatol 2004;33(5):362\u2013363. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1080\/03009740410005980","DOI":"10.1080\/03009740410005980"},{"key":"537_CR25","doi-asserted-by":"publisher","unstructured":"Khairallah M, Accorinti M, Muccioli C, Kahloun R, Kempen JH. Epidemiology of Beh\u00e7et disease. Ocul Immunol Inflamm 2012;20(5):324\u2013335. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.3109\/09273948.2012.723112","DOI":"10.3109\/09273948.2012.723112"},{"key":"537_CR26","doi-asserted-by":"publisher","unstructured":"Jari M, Shiari R, Salehpour O, Rahmani K. Epidemiological and advanced therapeutic approaches to treatment of uveitis in pediatric rheumatic diseases: a systematic review and meta-analysis. Orphanet J Rare Dis. 2020;15(1):41. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1186\/s13023-020-1324-x","DOI":"10.1186\/s13023-020-1324-x"},{"key":"537_CR27","doi-asserted-by":"publisher","unstructured":"Angeles-Han ST, McCracken C, Yeh S, Jenkins K, Stryker D, Rouster-Stevens K, et al. Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis. Pediatr Rheumatol Online J. 2015;13:19. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1186\/s12969-015-0018-8","DOI":"10.1186\/s12969-015-0018-8"},{"key":"537_CR28","doi-asserted-by":"publisher","unstructured":"Angeles-Han ST, Yeh S, Vogler LB. Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis. Int J Clin Rheumtol. 2013;8(1). Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.2217\/ijr.12.83","DOI":"10.2217\/ijr.12.83"},{"key":"537_CR29","doi-asserted-by":"publisher","unstructured":"Angeles-Han ST, McCracken C, Yeh S, Jenkins K, Stryker D, Travers C, et al. The association of race with childhood uveitis. Am J Ophthalmol. 2015;160(5):919\u201328.e1. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/j.ajo.2015.08.002","DOI":"10.1016\/j.ajo.2015.08.002"},{"key":"537_CR30","doi-asserted-by":"publisher","unstructured":"Butbul Aviel Y, Tyrrell P, Schneider R, Dhillon S, Feldman BM, Laxer R, et al. Juvenile Psoriatic Arthritis (JPsA): juvenile arthritis with psoriasis? Pediatr Rheumatol Online J. 2013;11(1):11. : https:\/\/doi.org\/https:\/\/doi.org\/10.1186\/1546-0096-11-11, Available from Juvenile Psoriatic Arthritis (JPsA): juvenile arthritis with psoriasis?.","DOI":"10.1186\/1546-0096-11-11"},{"key":"537_CR31","doi-asserted-by":"publisher","unstructured":"Castagna I, Roszkowska AM, Alessandrello F, Oliverio GW, Tumminello G, Gallizzi R, Conti G, Aragona P Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a Centre of South Italy. Int Ophthalmol 2020;40(2):335\u2013342. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1007\/s10792-019-01184-8","DOI":"10.1007\/s10792-019-01184-8"},{"key":"537_CR32","doi-asserted-by":"publisher","unstructured":"Heiligenhaus A, Heinz C, Edelsten C, Kotaniemi K, Minden K. Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors. Ocul Immunol Inflamm 2013;21(3):180\u2013191. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.3109\/09273948.2013.791701","DOI":"10.3109\/09273948.2013.791701"},{"key":"537_CR33","doi-asserted-by":"publisher","unstructured":"Khairallah M. Are the standardization of the Uveitis nomenclature (SUN) working group criteria for codifying the site of inflammation appropriate for all uveitis problems? Limitations of the SUN working group classification. Ocul Immunol Inflamm 2010;18(1):2\u20134. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/https:\/\/doi.org\/10.3109\/09273940903348835","DOI":"10.3109\/09273940903348835"},{"issue":"3","key":"537_CR34","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT. Others. Standardization of Uveitis nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509\u201316. https:\/\/doi.org\/10.1016\/j.ajo.2005.03.057.","journal-title":"Am J Ophthalmol"},{"key":"537_CR35","doi-asserted-by":"publisher","unstructured":"Constantin T, Foeldvari I, Anton J, de Boer J, Czitrom-Guillaume S, Edelsten C, et al. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative. Ann Rheum Dis 2018;77(8):1107\u20131117. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1136\/annrheumdis-2018-213131","DOI":"10.1136\/annrheumdis-2018-213131"},{"key":"537_CR36","doi-asserted-by":"publisher","unstructured":"Angeles-Han ST, Ringold S, Beukelman T, Lovell D, Cuello CA, Becker ML, Colbert RA, Feldman BM, Holland GN, Ferguson PJ, Gewanter H, Guzman J, Horonjeff J, Nigrovic PA, Ombrello MJ, Passo MH, Stoll ML, Rabinovich CE, Sen HN, Schneider R, Halyabar O, Hays K, Shah AA, Sullivan N, Szymanski AM, Turgunbaev M, Turner A, Reston J 2019 American College of Rheumatology\/Arthritis Foundation guideline for the screening, monitoring, and Treatment of Juvenile idiopathic Arthritis-associated Uveitis. Arthritis Care Res 2019;71(6):703\u2013716. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1002\/acr.23871","DOI":"10.1002\/acr.23871"},{"key":"537_CR37","doi-asserted-by":"publisher","unstructured":"Heiligenhaus A, Minden K, Tappeiner C, Baus H, Bertram B, Deuter C, Foeldvari I, F\u00f6ll D, Frosch M, Ganser G, Gaubitz M, G\u00fcnther A, Heinz C, Horneff G, Huemer C, Kopp I, Lommatzsch C, Lutz T, Michels H, Ne\u00df T, Neudorf U, Pleyer U, Schneider M, Schulze-Koops H, Thurau S, Zierhut M, Lehmann HW Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Semin Arthritis Rheum 2019;49(1):43\u201355. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/j.semarthrit.2018.11.004","DOI":"10.1016\/j.semarthrit.2018.11.004"},{"key":"537_CR38","doi-asserted-by":"publisher","unstructured":"Wulffraat NM, Vastert B, SHARE consortium. Time to share. Pediatr Rheumatol Online J. 2013;11(1):5. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1186\/1546-0096-11-5","DOI":"10.1186\/1546-0096-11-5"},{"key":"537_CR39","doi-asserted-by":"publisher","unstructured":"Ramanan AV, Dick AD, Jones AP, McKay A, Williamson PR, Compeyrot-Lacassagne S, Hardwick B, Hickey H, Hughes D, Woo P, Benton D, Edelsten C, Beresford MW Adalimumab plus methotrexate for Uveitis in Juvenile idiopathic Arthritis. N Engl J Med 2017;376(17):1637\u20131646. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1056\/NEJMoa1614160","DOI":"10.1056\/NEJMoa1614160"},{"key":"537_CR40","doi-asserted-by":"publisher","unstructured":"Quartier P, Baptiste A, Despert V, Allain-Launay E, Kon\u00e9-Paut I, Belot A, Kodjikian L, Monnet D, Weber M, Elie C, Bodaghi B, ADJUVITE Study Group. ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis. Ann Rheum Dis 2018;77(7):1003\u20131011. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1136\/annrheumdis-2017-212089","DOI":"10.1136\/annrheumdis-2017-212089"},{"key":"537_CR41","doi-asserted-by":"publisher","unstructured":"Miserocchi E, Modorati G, Berchicci L, Pontikaki I, Meroni P, Gerloni V. Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis. Br J Ophthalmol 2016;100(6):782\u2013786. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1136\/bjophthalmol-2015-306790","DOI":"10.1136\/bjophthalmol-2015-306790"},{"key":"537_CR42","doi-asserted-by":"publisher","unstructured":"Heiligenhaus A, Miserocchi E, Heinz C, Gerloni V, Kotaniemi K. Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab). Rheumatology 2011;50(8):1390\u20131394. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1093\/rheumatology\/ker107","DOI":"10.1093\/rheumatology\/ker107"},{"key":"537_CR43","doi-asserted-by":"publisher","unstructured":"Kenawy N, Cleary G, Mewar D, Beare N, Chandna A, Pearce I. Abatacept: a potential therapy in refractory cases of juvenile idiopathic arthritis-associated uveitis. Graefes Arch Clin Exp Ophthalmol 2011;249(2):297\u2013300. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1007\/s00417-010-1523-6","DOI":"10.1007\/s00417-010-1523-6"},{"key":"537_CR44","doi-asserted-by":"publisher","unstructured":"Tappeiner C, Mesquida M, Ad\u00e1n A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicu\u00f1a CG, Heiligenhaus A Evidence for Tocilizumab as a Treatment option in refractory Uveitis associated with Juvenile idiopathic Arthritis. J Rheumatol 2016;43(12):2183\u20132188. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.3899\/jrheum.160231","DOI":"10.3899\/jrheum.160231"},{"key":"537_CR45","doi-asserted-by":"publisher","unstructured":"Lopalco G, Fabiani C, Sota J, Lucherini OM, Tosi GM, Frediani B, Iannone F, Galeazzi M, Franceschini R, Rigante D, Cantarini L IL-6 blockade in the management of non-infectious uveitis. Clin Rheumatol 2017;36(7):1459\u20131469. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1007\/s10067-017-3672-z","DOI":"10.1007\/s10067-017-3672-z"},{"key":"537_CR46","doi-asserted-by":"publisher","unstructured":"Gaggiano C, Rigante D, Tosi GM, Vitale A, Frediani B, Grosso S, Fabiani C, Cantarini L Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-\u03b1 inhibition: a narrative review. Clin Rheumatol 2020;39(2):327\u2013337. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1007\/s10067-019-04763-3","DOI":"10.1007\/s10067-019-04763-3"},{"key":"537_CR47","unstructured":"Stats SA. Statistics South Africa. Formal census [Internet]. 2011; Available from: http:\/\/www.treasury.gov.za\/documents\/national%20budget\/2002\/ene\/vote_13.pdf. Accessed October 2019."},{"key":"537_CR48","doi-asserted-by":"publisher","unstructured":"Clarke SLN, Sen ES, Ramanan AV. Juvenile idiopathic arthritis-associated uveitis. Pediatr Rheumatol Online J. 2016;14(1):27. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1186\/s12969-016-0088-2","DOI":"10.1186\/s12969-016-0088-2"},{"key":"537_CR49","doi-asserted-by":"publisher","unstructured":"Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities \u201chand motion\u201d and \u201ccounting fingers\u201d can be quantified with the freiburg visual acuity test. Invest Ophthalmol Vis Sci 2006;47(3):1236\u20131240. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1167\/iovs.05-0981","DOI":"10.1167\/iovs.05-0981"},{"key":"537_CR50","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR. Pediatric rheumatology-ILAR classification of JIA: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"537_CR51","doi-asserted-by":"publisher","unstructured":"Kon\u00e9-Paut I. Beh\u00e7et\u2019s disease in children, an overview. Pediatr Rheumatol Online J. 2016;14(1):10. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1186\/s12969-016-0070-z","DOI":"10.1186\/s12969-016-0070-z"},{"issue":"4","key":"537_CR52","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","volume":"92","author":"RB Nussenblatt","year":"1985","unstructured":"Nussenblatt RB, Palestine AG, Chan C-C, Roberge F. Standardizatlon of Vitreal inflammatory activity in intermediate and posterior Uveitis. Ophthalmology. 1985;92(4):467\u201371. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0161642085340010. https:\/\/doi.org\/10.1016\/S0161-6420(85)34001-0.","journal-title":"Ophthalmology"},{"key":"537_CR53","doi-asserted-by":"publisher","unstructured":"Busch M, Wefelmeyer KL, Walscheid K, Rothaus K, Bauer D, Deeg CA, et al. Identification of ocular autoantigens associated with juvenile idiopathic arthritis-associated uveitis. Front Immunol. 2019;10:1793. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.3389\/fimmu.2019.01793","DOI":"10.3389\/fimmu.2019.01793"},{"key":"537_CR54","doi-asserted-by":"publisher","unstructured":"Vastert SJ, Bhat P, Goldstein DA. Pathophysiology of JIA-associated uveitis. Ocul Immunol Inflamm 2014;22(5):414\u2013423. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.3109\/09273948.2014.926937","DOI":"10.3109\/09273948.2014.926937"},{"key":"537_CR55","doi-asserted-by":"publisher","unstructured":"Weakley K, Esser M, Scott C. Juvenile idiopathic arthritis in two tertiary centres in the Western Cape, South Africa. Pediatr Rheumatol Online J. 2012;10(1):35. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1186\/1546-0096-10-35","DOI":"10.1186\/1546-0096-10-35"},{"key":"537_CR56","doi-asserted-by":"publisher","unstructured":"Olaosebikan BH, Adelowo OO, Animashaun BA, Akintayo RO. Spectrum of paediatric rheumatic diseases in Nigeria. Pediatr Rheumatol Online J. 2017;15(1):7. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1186\/s12969-017-0139-3","DOI":"10.1186\/s12969-017-0139-3"},{"key":"537_CR57","doi-asserted-by":"publisher","unstructured":"Furia FF, Godfrey E, Mwamanenge N, Swai P. spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania. Pediatr Rheumatol Online J. 2020;18(1):30. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1186\/s12969-020-0418-2","DOI":"10.1186\/s12969-020-0418-2"},{"key":"537_CR58","doi-asserted-by":"publisher","unstructured":"Bhimma R, Coovadia HM, Adhikari M. Improved outcome of systemic lupus erythematosus among children in Durban, South Africa. Ann Trop Paediatr 1994;14(2):119\u2013124. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1080\/02724936.1994.11747703","DOI":"10.1080\/02724936.1994.11747703"},{"key":"537_CR59","doi-asserted-by":"publisher","unstructured":"Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D. The burden of non-communicable diseases in South Africa. Lancet 2009;374(9693):934\u2013947. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/S0140-6736(09)61087-4","DOI":"10.1016\/S0140-6736(09)61087-4"},{"key":"537_CR60","doi-asserted-by":"publisher","unstructured":"Mayosi BM, Benatar SR. Health and health care in South Africa \u2014 20 years after mandela. N Engl J Med. 2014;371(14):1344\u20131353. https:\/\/doi.org\/https:\/\/doi.org\/10.1056\/NEJMsr1405012, Available from: Health and Health Care in South Africa \u2014 20 Years after Mandela.","DOI":"10.1056\/NEJMsr1405012"},{"key":"537_CR61","doi-asserted-by":"publisher","unstructured":"Lee JJY, Duffy CM, Guzman J, Oen K, Barrowman N, Rosenberg AM, Shiff NJ, Boire G, Stringer E, Spiegel L, Morishita KA, Lang B, Reddy D, Huber AM, Cabral DA, Feldman BM, Yeung RSM, Tucker LB, Watanabe Duffy K, for the ReACCh\u2010Out Investigators Prospective determination of the incidence and risk factors of new-onset Uveitis in Juvenile idiopathic Arthritis: the research in Arthritis in Canadian children emphasizing outcomes cohort. Arthritis Care Res 2019;71(11):1436\u20131443. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1002\/acr.23783","DOI":"10.1002\/acr.23783"},{"key":"537_CR62","doi-asserted-by":"publisher","unstructured":"Heiligenhaus A, Minden K, F\u00f6ll D, Pleyer U. Uveitis in juvenile idiopathic arthritis. Dtsch Arztebl Int 2015;112(6):92\u2013100, i. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.3238\/arztebl.2015.0092","DOI":"10.3238\/arztebl.2015.0092"},{"issue":"2","key":"537_CR63","first-page":"66","volume":"4","author":"GO Oyoo","year":"2016","unstructured":"Oyoo GO, Genga EK, Otieno FO, Omondi EA. Clinical patterns of juvenile idiopathic arthritis: a single tertiary center experience in Kenya. Afr J Rheumatol (AFLAR). 2016;4(2):66\u201371 Available from: https:\/\/www.researchgate.net\/publication\/306057270.","journal-title":"Afr J Rheumatol (AFLAR)"},{"key":"537_CR64","doi-asserted-by":"publisher","unstructured":"Abd El Latif E, Fayez Goubran W, El Gemai EEDM, Habib AE, Abdelbaki AM, Ammar H, et al. Pattern of childhood uveitis in Egypt. Ocul Immunol Inflamm. 2019;27(6):883\u2013889. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1080\/09273948.2018.1502325","DOI":"10.1080\/09273948.2018.1502325"},{"key":"537_CR65","doi-asserted-by":"publisher","unstructured":"Freedman J. Incidence of uveitis in bantu-speaking negroes of South Africa. Br J Ophthalmol 1974;58(6):595\u2013599. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1136\/bjo.58.6.595","DOI":"10.1136\/bjo.58.6.595"},{"key":"537_CR66","doi-asserted-by":"crossref","unstructured":"Freedman J. Anterior uveitis in bantu children. Br J Ophthalmol 1973;57(5):355\u2013358. Available from: http:\/\/dx.doi.org\/10.1136\/bjo.57.5.355","DOI":"10.1136\/bjo.57.5.355"},{"key":"537_CR67","doi-asserted-by":"publisher","unstructured":"Pasadhika S, Rosenbaum JT. Ocular Sarcoidosis. Clin Chest Med 2015;36(4):669\u2013683. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/j.ccm.2015.08.009","DOI":"10.1016\/j.ccm.2015.08.009"},{"key":"537_CR68","doi-asserted-by":"publisher","unstructured":"Morelle G, Gueudry J, Uettwiller F, Wouters C, Bader-Meunier B, Robert MP, et al. Chronic and recurrent non-infectious paediatric-onset uveitis: a French cohort. RMD Open. 2019;5(2):e000933. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1136\/rmdopen-2019-000933","DOI":"10.1136\/rmdopen-2019-000933"},{"key":"537_CR69","doi-asserted-by":"publisher","unstructured":"Wouters CH, Maes A, Foley KP, Bertin J, Rose CD. Blau syndrome, the prototypic auto-inflammatory granulomatous disease. Pediatr Rheumatol Online J. 2014;12:33. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1186\/1546-0096-12-33","DOI":"10.1186\/1546-0096-12-33"},{"key":"537_CR70","doi-asserted-by":"publisher","unstructured":"Nathan N, Marcelo P, Houdouin V, Epaud R, de Blic J, Valeyre D, Houzel A, Busson PF, Corvol H, Deschildre A, Clement A Lung sarcoidosis in children: update on disease expression and management. Thorax 2015;70(6):537\u2013542. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1136\/thoraxjnl-2015-206825","DOI":"10.1136\/thoraxjnl-2015-206825"},{"key":"537_CR71","doi-asserted-by":"publisher","unstructured":"Hoover DL, Khan JA, Giangiacomo J. Pediatric ocular sarcoidosis. Surv Ophthalmol 1986;30(4):215\u2013228. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/0039-6257(86)90118-9","DOI":"10.1016\/0039-6257(86)90118-9"},{"key":"537_CR72","doi-asserted-by":"publisher","unstructured":"Ajose FOA, Adelowo O, Oderinlo O. Clinical presentations of Beh\u00e7et\u2019s disease among Nigerians: a 4-year prospective study. Int J Dermatol 2015;54(8):889\u2013897. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1111\/ijd.12554","DOI":"10.1111\/ijd.12554"},{"issue":"4","key":"537_CR73","first-page":"175","volume":"27","author":"MEA Ghembaza","year":"2018","unstructured":"Ghembaza MEA, Lounici A. Relationship between age at onset and clinical characteristics of Beh\u00e7et\u2019s disease. Acta Dermatovenerol Alp Pannonica Adriat. 2018;27(4):175\u20137 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30564829.","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"537_CR74","doi-asserted-by":"publisher","unstructured":"Kilmartin DJ, Forrester JV, Dick AD. Cyclosporin a therapy in refractory non-infectious childhood uveitis. Br J Ophthalmol 1998;82(7):737\u2013742. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1136\/bjo.82.7.737","DOI":"10.1136\/bjo.82.7.737"},{"key":"537_CR75","doi-asserted-by":"publisher","unstructured":"Mathews D, Mathews J, Jones NP. Low-dose cyclosporine treatment for sight-threatening uveitis: efficacy, toxicity, and tolerance. Indian J Ophthalmol 2010;58(1):55\u201358. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.4103\/0301-4738.58472","DOI":"10.4103\/0301-4738.58472"},{"key":"537_CR76","doi-asserted-by":"publisher","unstructured":"Cecchin V, Zannin ME, Ferrari D, Pontikaki I, Miserocchi E, Paroli MP, Bracaglia C, Marafon DP, Pastore S, Parentin F, Simonini G, de Libero C, Falcini F, Petaccia A, Filocamo G, de Marco R, la Torre F, Guerriero S, Martino S, Comacchio F, Muratore V, Martini G, Vittadello F, Zulian F Longterm safety and efficacy of Adalimumab and infliximab for Uveitis associated with Juvenile idiopathic Arthritis. J Rheumatol 2018;45(8):1167\u20131172. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.3899\/jrheum.171006","DOI":"10.3899\/jrheum.171006"},{"key":"537_CR77","doi-asserted-by":"publisher","unstructured":"Simonini G, Taddio A, Cattalini M, Caputo R, De Libero C, Naviglio S, et al. Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab. Arthritis Care Res 2011;63(4):612\u2013618. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1002\/acr.20404","DOI":"10.1002\/acr.20404"},{"issue":"7","key":"537_CR78","first-page":"475","volume":"21","author":"L Gamalero","year":"2019","unstructured":"Gamalero L, Simonini G, Ferrara G, Polizzi S, Giani T, Cimaz R. Evidence-based treatment for uveitis. Isr Med Assoc J. 2019;21(7):475\u20139 Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31507124.","journal-title":"Isr Med Assoc J"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-021-00537-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12969-021-00537-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-021-00537-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T11:18:06Z","timestamp":1617275886000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-021-00537-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["537"],"URL":"https:\/\/doi.org\/10.1186\/s12969-021-00537-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-74889\/v1","asserted-by":"object"}]},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"21 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for data collection was obtained from the University of Cape Town human research ethics committee, HREC no: 692\/2018.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"WS has received sponsorships from Pfizer and Abbvie for conference attendance.CS has received conference attendance sponsorships and speaker fees from Abbvie, Pfizer and Roche.CT and NB declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}